Symposia
Program / Treatment Design
Liza Kolbasov, BA
Clinical Psychology PhD Student
Illinois Institute of Technology
Chicago, Illinois, United States
Arryn Guy, Ph.D. (she/they)
Illinois Institute of Technology
Chicago, IL, United States
Mikey Shock, BA
Clinical Psychology PhD Student
Illinois Institute of Technology
Chicago, IL, United States
Peyton Erb, BS
Clinical Research Assistant
Illinois Institute of Technology
Chicago, IL, United States
Kate Linenbach, BS
Clinical Psychology PhD Student
Illinois Institute of Technology
Chicago, IL, United States
Mayor Manlapid, BA
MPH Student
Brown University
Providence, RI, United States
Aya Shawari
Undergraduate research assistant
Illinois Institute of technology
Chicago, IL, United States
Self-stigma presents a critical barrier to healthcare engagement and well-being among transgender adults, particularly those with substance use concerns. This presentation details the development and refinement of the Trans-Led Care (TLC) Program, an Acceptance and Commitment Therapy (ACT)-based gender-affirming stigma reduction intervention. We will discuss specific aspects of the intervention content designed to address intersecting self-stigmas (e.g., transphobia, SUD and HIV stigma), including how the program uses adapted metaphors, mindfulness exercises, and self-actualization and safety values activities to help participants navigate internalized stigma while reducing substance use and HIV vulnerability. Considerations for adapting ACT to effectively target self-stigma among transgender adults who use substances will be explored, including the integration of gender-affirming principles and peer facilitation strategies. Findings from the open pilot (N=14 trans adults) demonstrated significant reductions in internalized stigma, with less clear signals on community connection, pride, and psychological flexibility. Qualitative feedback underscored the need for more session content practicing mindfulness, discussing substance use triggers, friend groups, and goal setting, as well as added considerations for neurodivergent participants. Final refinements to the intervention before randomized controlled trial (RCT) testing will be presented, with implications for scalability and implementation.